miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression
Authors
Keywords
-
Journal
PROSTATE
Volume 74, Issue 13, Pages 1320-1334
Publisher
Wiley
Online
2014-07-23
DOI
10.1002/pros.22848
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer
- (2013) Zsuzsanna Mihály et al. BREAST CANCER RESEARCH AND TREATMENT
- Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells
- (2013) Keith O’Brien et al. EUROPEAN JOURNAL OF CANCER
- Diagnostic usefulness of 18F-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma
- (2013) Aiko Nobusawa et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Clinicopathological Significance of L-type Amino Acid Transporter 1 (LAT1) Expression in Patients with Adenoid Cystic Carcinoma
- (2013) Kyoichi Kaira et al. PATHOLOGY & ONCOLOGY RESEARCH
- MIRUMIR: an online tool to test microRNAs as biomarkers to predict survival in cancer using multiple clinical data sets
- (2012) A V Antonov et al. CELL DEATH AND DIFFERENTIATION
- Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence
- (2012) M. T. Di Martino et al. CLINICAL CANCER RESEARCH
- High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas
- (2012) Nobuyuki Yanagisawa et al. JOURNAL OF CLINICAL PATHOLOGY
- MicroRNA-34a Modulates c-Myc Transcriptional Complexes to Suppress Malignancy in Human Prostate Cancer Cells
- (2012) Soichiro Yamamura et al. PLoS One
- Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomes
- (2012) Claire Corcoran et al. PLoS One
- Identifying mRNA, MicroRNA and Protein Profiles of Melanoma Exosomes
- (2012) Deyi Xiao et al. PLoS One
- miR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells
- (2011) Akira Tomokuni et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miRNA-34a is associated with docetaxel resistance in human breast cancer cells
- (2011) L. Kastl et al. BREAST CANCER RESEARCH AND TREATMENT
- Androgen Receptor and Nutrient Signaling Pathways Coordinate the Demand for Increased Amino Acid Transport during Prostate Cancer Progression
- (2011) Q. Wang et al. CANCER RESEARCH
- MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status
- (2011) Ruth L. Vinall et al. INTERNATIONAL JOURNAL OF CANCER
- miRWalk – Database: Prediction of possible miRNA binding sites by “walking” the genes of three genomes
- (2011) Harsh Dweep et al. JOURNAL OF BIOMEDICAL INFORMATICS
- Mir-148a Improves Response to Chemotherapy in Sensitive and Resistant Oesophageal Adenocarcinoma and Squamous Cell Carcinoma Cells
- (2011) Richard Hummel et al. JOURNAL OF GASTROINTESTINAL SURGERY
- miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy
- (2011) Fumihiko Nakatani et al. JOURNAL OF PATHOLOGY
- ALIX/AIP1 Is Required for NP Incorporation into Mopeia Virus Z-Induced Virus-Like Particles
- (2011) O. Shtanko et al. JOURNAL OF VIROLOGY
- Characterisation and manipulation of docetaxel resistant prostate cancer cell lines
- (2011) Amanda J O'Neill et al. Molecular Cancer
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
- (2011) Can Liu et al. NATURE MEDICINE
- MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer
- (2011) Bin Xu et al. PROSTATE
- Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells
- (2011) María Mittelbrunn et al. Nature Communications
- Docetaxel-based combination therapy for castration-resistant prostate cancer
- (2010) M. D. Galsky et al. ANNALS OF ONCOLOGY
- Secretion of extracellular hsp90α via exosomes increases cancer cell motility: a role for plasminogen activation
- (2010) Jessica McCready et al. BMC CANCER
- MicroRNA and drug resistance
- (2010) J Ma et al. CANCER GENE THERAPY
- Intracellular and Extracellular MicroRNAs in Breast Cancer
- (2010) C. Corcoran et al. CLINICAL CHEMISTRY
- Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin
- (2010) Igor P. Pogribny et al. INTERNATIONAL JOURNAL OF CANCER
- MiR-148a Attenuates Paclitaxel Resistance of Hormone-refractory, Drug-resistant Prostate Cancer PC3 Cells by Regulating MSK1 Expression
- (2010) Yasunori Fujita et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tamm-Horsfall protein and urinary exosome isolation
- (2010) Patricia Fernández-Llama et al. KIDNEY INTERNATIONAL
- Use and Assessment of PSA in Prostate Cancer
- (2010) Carl K. Gjertson et al. MEDICAL CLINICS OF NORTH AMERICA
- miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma
- (2010) Shyamal D. Weeraratne et al. NEURO-ONCOLOGY
- Parkinson's Disease-Related Protein, α-Synuclein, in Malignant Melanoma
- (2010) Yasuhiro Matsuo et al. PLoS One
- Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells
- (2010) Lucy Pigati et al. PLoS One
- MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms
- (2010) Keitaro Kojima et al. PROSTATE
- miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression
- (2010) T Murata et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Exosomal MicroRNA: A Diagnostic Marker for Lung Cancer
- (2009) Guilherme Rabinowits et al. Clinical Lung Cancer
- Astrocytes and Glioblastoma cells release exosomes carrying mtDNA
- (2009) Michele Guescini et al. JOURNAL OF NEURAL TRANSMISSION
- Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells
- (2008) Yasunori Fujita et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
- (2008) Douglas D. Taylor et al. GYNECOLOGIC ONCOLOGY
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
- (2008) Johan Skog et al. NATURE CELL BIOLOGY
- L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer
- (2008) Takeshi Sakata et al. PATHOLOGY INTERNATIONAL
- Serum MicroRNAs Are Promising Novel Biomarkers
- (2008) Shlomit Gilad et al. PLoS One
- Detection of microRNA Expression in Human Peripheral Blood Microvesicles
- (2008) Melissa Piper Hunter et al. PLoS One
- Loss of mir-146a function in hormone-refractory prostate cancer
- (2008) S.-L. Lin et al. RNA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now